AstraZeneca Profit Sags as Coronavirus Slows Diagnoses

(Bloomberg) -- AstraZeneca Plc’s third-quarter profit fell short of analysts’ estimates as the pandemic inflated costs and discouraged some doctors’ visits and diagnoses.